Results 61 to 70 of about 6,662 (219)

Is it time to offer routine screening for iron deficiency in healthy adolescent females?

British Journal of Haematology, EarlyView.
Given the high prevalence of iron deficiency (ID) in adolescents and the significant health consequences it entails, we recommend screening all female adolescents for ID using serum haemoglobin and ferritin, starting at age 14–15 (approximately 3 years post‐menarche) and repeating every 5 years.
Shoshana Revel‐Vilk, Tal Ben‐Ami, Naama Constantini   +2 more
wiley   +1 more source

Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding

Orphanet Journal of Rare Diseases, 2020
Background Hereditary Hemorrhagic Telangiectasia (HHT) is a rare inherited disorder characterized by development of mucocutaneous telangiectases and visceral organ arteriovenous malformations, which can lead to recurrent, spontaneous bleeding and ...
Joan D. Beckman, Quefeng Li, Samuel T. Hester, Ofri Leitner, Karen L. Smith, Raj S. Kasthuri   +5 more
doaj   +1 more source

Bench-to-bedside review: the role of activated protein C in maintaining endothelial tight junction function and its relationship to organ injury. [PDF]

, 2006
Activated protein C (APC) has emerged as a novel therapeutic agent for use in selected patients with severe sepsis, even though the mechanism of its benefit is not well established.
Looney, Mark R, Matthay, Michael A
core   +2 more sources

Management of pregnancy and childbirth in Glanzmann thrombasthenia: A case series and review

British Journal of Haematology, EarlyView.
To illustrate the challenges in the management of women with Glanzmann thrombasthenia (GT) planning a pregnancy, we conducted a literature review and present a case series of eight women giving detailed descriptions of reproductive health problems, platelet alloimmunisation, treatment to prevent post‐partum haemorrhage and neonatal outcomes.
Karlijn H. G. Rutten, Olga Tsiamita, Quentin Van Thillo, Priyanka Raheja, Mandeep Kaler, Karin P. M. van Galen, Matthew Hogg, Louise Bowles, Roger E. G. Schutgens, Suthesh Sivapalaratnam   +9 more
wiley   +1 more source

The use of fibrinolysis inhibitors in cardiac surgery with cardiopulmonary bypass (literature review)

Вестник анестезиологии и реаниматологии
In cardiac surgery with cardiopulmonary bypass (CPB) is a common complication. The incidence of this complication in cardiac surgery patients is estimated at about 10%.
V. Yu. Medvedeva, K. N. Khrapov, A. A. Khryapa, K. Yu. Kankova   +3 more
doaj   +1 more source

Subarachnoid lavage following inadvertent intrathecal injection of tranexamic acid

Ibom Medical Journal, 2022
Tranexamic acid (TXA) is a commonly used antifibrinolytic drug during surgical procedures to reduce blood loss. An Inadvertent intrathecal injection of TXA may lead to serious side effects including seizures and ventricular fibrillation with reported ...
Salahu D, Abdullahi MM, Abdullahi H, Adeleke N, Adesope S, Aliyu LD, Hassan MM, Alhassan DM, Mamuda A, Abdurrahman A, Adamu SM, Mohammed AM, Ahmed AI, Sadiq GU, Alfa AM, Usman NM, Takai UI   +16 more
doaj   +1 more source

Effectiveness of Octocog Alfa (BAY 81‐8973) to Treat People With Haemophilia A Enrolled in the ATHNdataset, Including Under‐Represented Subgroups

European Journal of Haematology, EarlyView.
ABSTRACT Objectives To evaluate the real‐world effectiveness of octocog alfa (BAY 81‐8973; Kovaltry) in people with haemophilia A (PwHA), including under‐represented subgroups. Methods We retrospectively analysed the American Thrombosis and Hemostasis Network (ATHN) dataset to identify the characteristics, treatment/clinical histories and annualised ...
Martin Chandler, Thomas Moulton, Lena Charafi, Jessica Charlet, Michael Recht   +4 more
wiley   +1 more source

The impact of Cochrane Systematic Reviews : a mixed method evaluation of outputs from Cochrane Review Groups supported by the UK National Institute for Health Research [PDF]

, 2014
© 2014 Bunn et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and ...
A Boaz, A Coffey, A Jorgensen, AM Moseley, C Ham, C Weiss, CE Estabrooks, CJ Cates, CJ Cates, CJ Cates, D Gillies, DL Sackett, E McInnes, European Medicines Agency, F Bunn, F Bunn, H Piwowar, HEFC, HT Martin, I Roberts, I Roberts, ID Cameron, J Burnett, J Comroe, J Grimshaw, J Grimshaw, J Lavis, J Lomas, J Ryan, JM Grimshaw, K Oliver, L Becker, L Thomas, LD Gillespie, LI Meho, M Buxton, M Dawes, M Gold, M Huberman, ME Falagas, N Black, O Olsen, P Lockhart, P Perel, P Perel, PA Sabatier, S Hanney, S Hanney, S Ismail, S Kuruvilla, S Kuruvilla, S Nutley, S Peckham, SE Cozzens, SR Hanney, TA Sheldon, TA Sheldon, TN van Leeuwen   +57 more
core   +2 more sources

Dental Management for People With Congenital Haemophilia: A Systematic Review of the Existing Dental Recommendations

Haemophilia, EarlyView.
ABSTRACT Introduction Haemophilia is the most common inherited bleeding disorder. Dental management for people with haemophilia (PwH) (both A and B) is challenging, as dental procedures may initiate bleeding episodes that may be difficult to control. Objectives This systematic review aimed to evaluate and summarize the existing dental guidelines that ...
Mathangi Kumar, Sulochana Badagabettu, Keerthilatha M. Pai, Judith Angelitta Noronha, Baby S. Nayak, Penny McCarthy   +5 more
wiley   +1 more source

European Management of Glanzmann's Thrombasthenia: A Survey of Current Clinical Practice

Haemophilia, EarlyView.
ABSTRACT Introduction Glanzmann's thrombasthenia is a rare inherited platelet disorder characterized by a lack of platelet aggregation. Patients tend to be diagnosed in early childhood with treatment strategies involving a multifaceted approach to prevent and manage bleeding episodes.
Mathieu Fiore, Andrea Artoni, Robert Klamroth, Mary Mathias, Roger Schutgens, Roseline d'Oiron, EAHAD Glanzmann Thrombasthenia Working Group   +6 more
wiley   +1 more source